Alsieni, M., Babader, R., Kenany, S., Abdulgader, S., Alafif, R., Alahmadi, A., Aloufi, A., Fallatah, E., AlQahtani, R. and Izaldin, A. 2024. The prevalence Regarding the Use of Glucagon-like Peptide-1 (GLP-1) Agonists as an Obesity Treatment among Adult Patients at King Abdulaziz University Medical Services Center, Jeddah, Saudi Arabia: a Descriptive Cross-Sectional Study: The prevalence of Glucagon-like Peptide-1 (GLP-1) Agonists use as an Obesity Treatment among adults in Saudi Arabia. Journal of King Abdulaziz University: Medical Sciences. 31, 2 (Dec. 2024).